Dinesh V. Patel is the President and CEO of Protagonist Therapeutics, a company at the forefront of developing novel peptide therapeutics. With over 38 years of experience in the pharmaceutical and biotechnology industries, Patel has led Protagonist Therapeutics since 2008, guiding it through significant growth and innovation. His extensive background includes leadership roles at several other biotech firms, where he has driven successful drug development and strategic acquisitions.
Who is the CEO of Protagonist Therapeutics?
With a Ph.D. in Chemistry from Rutgers University and extensive experience in the pharmaceutical and biotechnology sectors, Dinesh V. Patel has been a pivotal figure in the industry. Before becoming the CEO of Protagonist Therapeutics in 2008, Patel held leadership roles at Arête Therapeutics, Miikana Therapeutics, Versicor, Affymax, and Bristol-Myers Squibb. His career is marked by significant achievements, including the development of two marketed drugs and the successful acquisition of Vicuron by Pfizer.
Patel's visionary leadership at Protagonist Therapeutics has driven the company to the forefront of peptide therapeutic innovation, advancing treatments for various diseases.
Work History
Dinesh V. Patel's extensive work history in the pharmaceutical and biotechnology industries includes several notable positions:
- Protagonist Therapeutics - President and CEO (2008 - Present)
- Arête Therapeutics - Leadership Role
- Miikana Therapeutics - Leadership Role
- Versicor - Leadership Role
- Affymax - Leadership Role
- Bristol-Myers Squibb - Leadership Role
Education History
Dinesh V. Patel's educational journey laid a strong foundation for his illustrious career in the pharmaceutical and biotechnology industries. He earned his Ph.D. in Chemistry from Rutgers University, where he honed his expertise in the field. Prior to that, Patel completed his undergraduate studies in India, obtaining a Bachelor's degree in Chemistry. His academic background, characterized by rigorous training and a deep understanding of chemical sciences, has been instrumental in his ability to lead and innovate in various high-profile roles throughout his career.
When did Dinesh V. Patel join Protagonist Therapeutics?
Dinesh V. Patel joined Protagonist Therapeutics in December 2008, taking on the role of President and CEO. With his extensive background in the pharmaceutical and biotechnology industries, Patel has been instrumental in steering the company towards significant advancements in peptide therapeutics. Having been with Protagonist Therapeutics for over a decade, his leadership has been pivotal in the company's growth and innovation. Patel's tenure at Protagonist Therapeutics spans more than 14 years, during which he has consistently driven the company forward in developing novel treatments for various diseases.